Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Paragon Therapeutics, Inc. And WuXi Biologics Entered Into A Biologics Master Services Agreement, Which Was Later Transferred To Aeglea Biotherapeutics, Inc., Governing Development Activities And Manufacturing For The Company's SPY001 Program

Author: Benzinga Newsdesk | September 25, 2023 03:17pm

- SEC Filing

Posted In: AGLE